Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Yasuyuki Okada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1867-8800; OpenAlex author ID A5002850337. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Conditions for effective use of liposomal irinotecan with fluorouracil and leucovorin in unresectable pancreatic cancer after FOLFIRINOX treatment. Co-author DOI 10.1007/s10147-024-02677-y↗
  2. Exosomal miR-199a-3p Secreted From Cancer-Associated Adipocytes Promotes Pancreatic Cancer Progression. Co-author DOI 10.1002/cam4.70265↗
  3. Corrigendum to "Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma" [Semin. Cancer Biol. 75 (2021) 153-168]. First author DOI 10.1016/j.semcancer.2022.01.002↗
  4. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2020.12.031↗
  5. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.semcancer.2020.10.001↗
  6. LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinom… Co-author DOI 10.1093/carcin/bgab011↗
  7. A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1007/s00280-015-2835-3↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tetsuji Takayama · 5 shared papers, 2015–2025 · strength 0.78
  2. Ajay Goel · 4 shared papers, 2021–2022 · strength 0.75
  3. Geeta G. Sharma · 2 shared papers, 2021–2022 · strength 0.42
  4. Daniel D. Von Hoff · 2 shared papers, 2021–2022 · strength 0.42
  5. Masanori Takehara · 2 shared papers, 2015–2024 · strength 0.22
  6. Kazuyoshi Noda · 1 shared paper, 2024 · strength 0.18
  7. Satoshi Nishiwada · 1 shared paper, 2021 · strength 0.15
  8. Hideo Baba · 1 shared paper, 2021 · strength 0.15
  9. Masayuki Sho · 1 shared paper, 2021 · strength 0.15
  10. Kensuke Yamamura · 1 shared paper, 2021 · strength 0.15
  11. Takahiro Goji · 1 shared paper, 2015 · strength 0.03
  12. Jun Okazaki · 1 shared paper, 2015 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.